Abstract BACKGROUND: Glucosamine hydrochloride (GlcNÁHCl) has been shown to inhibit cell growth and matrix synthesis, but not with N-acetyl-glucosamine (GlcNAc) supplementation. This effect might be related to an inhibition of critical growth factors (GF), or to a different metabolization of the two glucosamine derivatives. The aim of the present study was to evaluate the synergy between GlcNÁHCl, GlcNAc, and GF on proliferation and cartilage matrix synthesis. METHOD: Bovine chondrocytes were cultivated in monolayers for 48 h and in three-dimensional (3D) chitosan scaffolds for 30 days in perfusion bioreactors. Serum-free (SF) medium was supplemented with either growth factors (GF) TGF-b (5 ng mL -1 ) and IGF-I (10 ng mL -1 ), GlcNÁHCl or GlcNAc at 1mM each or both. Six groups were compared according to medium supplementation: (a) SF control; (b) SF ? GlcNÁHCl; (c) SF ? GlcNAc; (d) SF ? GF; (e) SF ? GF ? GlcNÁHCl; and (f) SF ? GF ? GlcNAc. Cell proliferation, proteoglycan, collagen I (COL1), and collagen II (COL2) synthesis were evaluated. RESULTS: The two glucosamines showed opposite effects in monolayer culture: GlcNÁHCl significantly reduced proliferation and GlcNAc significantly augmented cellular metabolism. In the 30 days 3D culture, the GlcNÁHCl added to GF stimulated cell proliferation more than when compared to GF only, but the proteoglycan synthesis was smaller than GF. However, GlcNAc added to GF improved the cell proliferation and proteoglycan synthesis more than when compared to GF and GF/GlcNÁHCl. The synthesis of COL1 and COL2 was observed in all groups containing GF. CONCLUSION: GlcNÁHCl and GlcNAc increased cell growth and stimulated COL2 synthesis in long-time 3D culture. However, only GlcNAc added to GF improved proteoglycan synthesis.
Introduction
Glucosamine (GlcN-abbreviation for general formula) is a hexosamine monosaccharide with potential effects to act as a chondrogenic and chondroprotector substance when prescribed as a supplement for osteoarthritis. GlcN assists in the healing process by inhibiting pro-inflammatory cytokine agents [1] [2] [3] , it suppresses the degradation of the matrix by blocking proteases [4] and aggrecanases [5, 6] , it stimulates chondrocyte proliferation and differentiation [7] , and it might also be used as a substrate for glycosaminoglycan synthesis [8] [9] [10] [11] . Nevertheless, the effect on cell proliferation and biosynthesis is controversial [12, 13] .
GlcN enters cells via glucose transporter proteins (GLUTs) [14, 15] and it is metabolized in uridine-diphosphate-N-acetylglucosamine (UDP-N-GlcNAc) [16] through the hexosamine biosynthesis pathway (HBP) [17] . UDP-NGlcNAc is the substrate for O-linked-N-acetylglucosamine transferase enzyme (OGT), which promotes the O-linked GlcNAcylation of serine/threonine residues of many nucleocytoplasmic proteins, kinases, and transcription factors [18] [19] [20] . This post-translational modification modulates the function and fate of these proteins, regulating many cellular processes such as signaling dynamics and gene expression [19] . The beneficial effect of exogenous GlcN might be related to an increase of O-GlcNAcylation. Low doses of GlcN increase O-GlcNAcylation of the hyaluronan synthase enzyme (HAS) [21] . It protects HAS from proteases by improving the stability and stimulates the synthesis of hyaluronan, which is an important proteoglycan of articular cartilages. Additionally, GlcN increases the O-GlcNAcylation of Sp1 transcription factor upregulating the expression of the transforming growth factor beta (TGF-b) type I [18] .
The stimulation of TGF-b expression has a positive effect on chondrogenesis. TGF-b binds to type II receptor (TGF-rII) and recruits type I receptor (TGF-rI), also called activin-like kinase (ALK) 1-7 [22] . The activation of ALK5 downstream smad2/3, MEK-ERK1/2-ELK1/2, and PI3K-AKT-mTOR pathways, These pathways are responsible for cell proliferation, and collagen II [13, [23] [24] [25] and aggrecan [22, 23, 25, 26] expressions. The Insulin-like growth factors (IGF) are also critical for cartilage homeostasis. Their anabolic effect is additive to the effects of TGF-bs but independent [27] . IGF-1 phosphorylates the IGF-1 receptor (IGF-Ir). This phosphorylation and conformational change of IGF-Ir permits the phosphorylation of the insulin receptor-1 (IRS-1) [28] , which downstream MEK-ERK1/2 and Akt-mTOR pathways. The first pathway stimulates cell proliferation [28] and proteoglycan synthesis [29] , while the second stimulates collagen II expression [30] .
Glucose is considered the main precursor and a critical energy source for chondrogenic differentiation [31] and matrix synthesis in cartilage [15, 32] . However, the imbalance of nutrition such as hyperglycemia has been linked to the hypertrophy of chondrocytes and development of osteoarthritis through the increase of O-GlcNAcylation. High concentrations of glucose (20-30 mM) stimulate the O-GlcNAcylation of several kinases, including PKC [33] . This modification inhibits the phosphorylation and activity of PKC, down-regulating the TGF-rII expression [33] . This pathological mechanism may explain the decreased TGF-rII expression and TGF-b activity in osteoarthritic chondrocytes [34] , despite the enhancement of TGF-b expression found in osteoarthritis [35] . On the other hand, contradicting results have been shown in smooth muscle cells [36] and dental pulp stem cells [17] , which however might have a completely different glucose metabolism. The proliferation induced by high glucose was related to an overexpression of TGF-rII stimulated by PKC [36] , and GlcN and GlcNAc stimulated the expression of TGF-rI [17] . The IGF-I signaling also appears to be tightly modulated by post-translational modification of IGF-Ir and IRS-1, since exogenous GlcN increases the O-GlcNAcylation of serine/threonine residues of IRS-1 [37] and IGF-Ir [38] . This modification inhibited the phosphorylation of IRS-1 and the Akt downstream [39] , resulting in insulin resistance, decreased glucose uptake [39] , and inhibition of proliferation [38] .
The association of the nutritional state and inhibition of TGF-rII and IGF-Ir expressions give rise to the hypothesis that GlcN reduces the chondrogenic effect of these two growth factors, which could explain the inhibition of cell proliferation and matrix synthesis after GlcN addition to medium containing native growth factors included in fetal bovine serum (FBS) [40] [41] [42] . Therefore, the present study evaluated the effect of two GlcNs-glucosamine hydrochloride (GlcNÁHCl) and N-acetylglucosamine (GlcNAc), which have hitherto shown differential biological activities [43] , solely or in combination with TGF-b and IGF-I, on the biosynthesis and proliferation of chondrocytes seeded in chitosan scaffolds for cartilage engineering. The use of serum-free medium is a more reliable design due to the absence of other molecules present in FBS that could interfere in the results. However, first the expression of the glucose transporter type II (GLUT2), which has higher affinity for GlcN than for glucose [44] was confirmed, and then the effect of GlcNÁHCl and GlcNAc doses on proliferation in monolayer cultures was evaluated, individually and in crosstalk with TGF-b and IGF-I.
Materials and methods

Materials
The composition of the medium was: DMEM/F12 high glucose medium, dexamethasone, ascorbate 2-phosphate, fetal bovine serum (FBS), GlcNÁHCl, and GlcNAc (Sigma Aldrich, Darmstadt, Germany), AlbuMax (Thermo Scientific, Schwerte, Germany), penicillin/streptomycin (GE Healthcare, Freiburg, Germany), transferrin-selenite (Fisher Scientific, Germany), collagenase IV (Invitrogen, Darmstadt, Germany), TGF-b3 (R&D Systems, Wiesbaden, Germany), and IGF-I (PeproTech, Hamburg, Germany). The 3D scaffold was prepared with chitosan (99% purity and deacetylation degree; Heppe Medical Chitosan GmbH (HMC ? ), Halle, Germany) and glutaraldehyde solution (Sigma Aldrich, Darmstadt, Germany). Immunohistochemistry was evaluated with anti-GLUT2 antibody (Abcam 111117, Darmstadt, Germany), rabbit polyclonal anti-collagen I (Abcam AB34710, Darmstadt, Germany), secondary polyclonal antibody Goat Anti-rabbit IgG H&L (Biotin) (Thermo Scientific, Schwerte, Germany), mouse polyclonal anti-collagen 2, secondary polyclonal antibody anti-Goat/ Sheep IgG (R&D Systems, Wiesbaden, Germany), pierce peroxidase immunohistochemistry detection kit (Thermo Scientific, Schwerte, Germany). The evaluation of the proliferation was performed with the Quanti-iT Pico Green dsDNA assay kit (Thermo Scientific, Schwerte, Germany), and the resazurin Kit (Sigma Aldrich, Darmstadt, Germany). The absorbance and fluorescence were analyzed in a Polar Star Optima spectrophotometer (BMG LabTech GmbH, Ortemberg, Germany). The lactate production was measured in a Labtrend (BST, Berlin, Germany).
Primary cell isolation and cultivation
Primary chondrocytes were isolated from bovine carpal joints. Briefly, the articular cartilage tissue obtained was cultivated in DMEM/F12 high glucose medium supplemented with 1% penicillin/streptomycin, and 1 mg mL
). The suspension was centrifuged at 200 g for 5 min and resuspended in DMEM/F12 high glucose medium supplemented with 10% FBS, 0.1% AlbuMax, 1% v/v penicillin/streptomycin, and 1% v/v transferrin-selenite. Chondrocytes from passage 4-9 were used in the two-dimensional (2D) and 3D experiments. All cells were cultivated at 37°C, 5% CO 2 , and under normoxic conditions.
GLUT2 expression
For the evaluation of the GLUT2 expression, 10 9 10 3 chondrocytes were cultivated in chamber slides for 24 h at 37°C, 5% CO 2 in high glucose medium. The cells were fixed with 4% formaldehyde for 2 h, rinsed 3 times with TBS ? Tween 20. Blocking was achieved by incubating the samples for 30 min with 1% bovine albumin serum in PBS, incubated with anti-GLUT2 antibody and anti-goat/ sheep IgG antibody for 1 h at room temperature. Peroxidase labeled streptavidin-biotin was used as the detection system counterstained with Harris modified hematoxylin according to the manufacturer's protocol.
Chondrocyte monolayer culture
Bovine chondrocytes were seeded in 96 well plates at a concentration of 5 9 10 3 in 100 lL medium per well, and cultivated for 3 h for cell adhesion. After cell adhesion, the medium was changed to serum-free medium containing DMEM/F12 high glucose medium, 0.1% AlbuMax, 1% penicillin/streptomycin, 170 lL dexamethasone at a concentration of 2 mg mL -1 , 1% transferrin-selenite, 0.01% ascorbate 2-phosphate, supplemented with GlcNÁHCl or GlcNAc at concentrations of 1 lM, 0.5 mM, 1 mM, 5 mM, and 10 mM. The best concentration of GlcNÁHCl and GlcNAc was used to study the interaction with TGFb3 ? IGF-I. Three groups were formed. The serum-free medium was supplemented with GF, GF/GlcNÁHCl, and GF/GlcNAc. For both experiments the same medium without GlcNÁHCl or GlcNAc was used as control. The cells were cultivated for 72 h, at 37°C, 5% CO 2 , and under normoxic conditions. All experiments were carried out in duplicate.
Cell proliferation quantification
Cell proliferation was evaluated using three methods according to the manufacturer's protocol: (1) measurement of the dsDNA concentration with 5 lL mL -1 Quanti-iT Picogreen assay (excitation 480 nm/emission 520 nm), (2) measurement of the redox reaction of 2% resazurin in resorufin (excitation 560 nm/emission 590 nm) by NADPH/NADH with incubation for 2 h, and (3) measurement of the lactate production. The production of lactate was measured aliquoting 20 lL of sample medium and diluting it in 1 mL of measuring system solution.
3D scaffold synthesis
Porous chitosan sponge scaffolds were produced as described before [45] . Chitosan powder was solubilized in a 0.1 N HCl/deionized water solution at a concentration of 2%. The pH of this solution was adjusted to 5 by adding 1 N NaOH. Chitosan was crosslinked by adding 1% glutaraldehyde in a 1:1 proportion. This solution was poured into a mold with a height of 4 mm and a diameter of 14 mm, frozen for 12 h, lyophilized for 12 h, and sterilized with gamma irradiation. The scaffold and internal structure can be seen in Fig. 1 .
Cell cultivation in 3D scaffold
The scaffolds were washed with medium to balance the pH for 14 h changing the medium 3 times. One million bovine chondrocytes resuspended in 100 lL medium were seeded on top of the scaffold and incubated for 20 min for cell adhesion at 37°C, 5% CO 2 , to allow cell adhesion. After adhesion, the samples were cultivated for 24 h in DMEM/ F12 high glucose supplemented with 10% FBS, 0.1% AlbuMax, 1% penicillin/streptomycin, and 1% transferrinselenite. The scaffolds were transferred into perfusion bioreactors and cultivated for 30 days in serum-free medium as described above, supplemented with GlcNÁHCl, GlcNAc, GF, GF ? GlcNÁHCl, and GF ? GlcNAc; pure SF medium served as control. The concentrations of GF were 5 ng mL -1 TGF-b3 and 10 ng mL -1 IGF-I. The GlcNÁHCl and GlcNAc concentrations were defined in the monolayer experiment described above. A total of 200 mL of medium per bioreactor was used and perfused with a flow velocity of 1 mL min -1 . The sample size of each treatment group was 3.
Histology, immunohistochemistry and scanning electron microscopy
The 3D matrix samples were fixed in 4% formaldehyde for 12 h, dehydrated in a series of graded ethanol with Roticlear, embedded in paraffin, and cut into 6 lm sections that were stained with hematoxylin & eosin to evaluate cell proliferation, and Alcian Blue pH 2.5 for proteoglycans. The peroxidase labeled streptavidin-biotin immunohistochemistry detection system was performed to evaluate the synthesis of COL1 and COL2. The primary antibodies were applied and allowed to react for 12 h, the secondary antibody reacted for 30 min, and finally the samples were counterstained with Harris modified hematoxylin for 1 min. For scanning electron microscopy (SEM), the samples were fixed in aqueous 0.2 M sodium cacodylate trihydrate containing 1% glutaraldehyde, 2% formaldehyde and 5% sucrose solution for 4 h, followed by an equal fixation period in 0.2 M sodium cacodylate trihydrate, 3% glutaraldehyde, and 3% formaldehyde solution, dehydrated in an ascending acetone series, dried in an overcritical process of CO 2 , and sputter-coated with carbon and gold.
Statistical analysis
The one-way single factor analysis of variance (ANOVA) with the Tukey post hoc test or the Kruskal-Wallis rank sum test with the Nemeniy post hoc test were used at a significance level of 0.05.
Results
Evaluation of GLUT-2 expression
The IHC of plated chondrocytes clearly showed positive staining of GLUT-2, and no background was observed in control without the primary antibody (Fig. 2) . Thus, the GLUT-2 transporter is present in the bovine chondrocytes used in the experiment. 
Effect of GlcNÁHCl and GlcNAc concentration on chondrocyte proliferation
In order to establish a possible dose-response relationship for the effect of the glucosamines on cell proliferation, we tested a range from 1 lM to 10 mM of both substances. The concentration of 1 lM estimated the viable concentration in synovia fluid after an oral dose of 1500 mg of GlcN [46, 47] . The results are shown in the supplementary section. A high concentration (10 mM) of GlcNÁHCl showed the lowest cell proliferation and lactate production, while there was no difference between the concentrations below 1 mM. The concentrations of 1 and 10 mM resulted in the highest cell proliferation, whereas 1 mM GlcNAc resulted in the highest lactate production. Neither GlcNÁHCl nor GlcNAc supplementations altered the resazurin metabolization. Therefore, the concentration of GlcNÁHCl and GlcNAc for the next experiments was set at 1 mM due to the GlcNAc effect.
Effect of GlcNÁHCl, GlcNAc and growth factors synergy on cell monolayer proliferation
The three parameters evaluated showed a striking difference between the two glucosamines on cell proliferation ( Fig. 3 and Table 1 ). The addition of GlcNÁHCl alone did not change the proliferation compared to control for all parameters measured (p [ 0.91), and had a strong inhibitory effect in combination with GF, producing the lowest values for all parameters (p \ 0.001 compared to GF). On the other hand, although GlcNAc alone only increased the DNA concentration slightly (p [ 0.378), the lactate values increased significantly compared to control and GlcNÁHCl (p \ 0.01). The resazurin redox was similar between them (p [ 0.75). Combined to GF, GlcNAc produced similar proliferation (p [ 0.127), but slightly higher lactate production compared to GF (p \ 0.05). Therefore, the addition of GlcNAc to GF led to higher metabolic activity, since the number of cells was similar to GF, while the reduced values of lactate and resazurin redox obtained for GlcNÁHCl ? GF correlated with the low dsDNA values and thus might be a consequence of a lower number of cells.
Effect of GlcNÁHCl, GlcNAc and GF synergy on cell proliferation and biosynthesis in 3D culture
Cell distribution and proteoglycan synthesis are shown in Figs. 4 and 5, respectively. The data are summarized in Table 2 . GlcNÁHCl and GlcNAc without growth factors did not alter the cell proliferation compared to control. This low cell density was responsible for a very low proteoglycan synthesis. On the other hand, higher cell proliferation and proteoglycan synthesis were observed in groups with GF supplementation. Among these groups, the addition of GlcNÁHCl (p \ 0.001) and GlcNAc (p \ 0.001) to GF clearly improved the cell proliferation compared to GF. However, the proliferation was higher in GF/GlcNAc than GF/GlcNÁHCl (p \ 0.001) in concordance with the 2D culture result t. Although the addition of GlcNÁHCl to GF stimulated cell proliferation, the proteoglycan synthesis was slightly lower (min: 1.95, max: 8.27% of total area) compared to GF (min: 4.36, max: 8.88% of total area), but not significantly different (p = 0.663). the addition of GlcNAc to GF (min: 8.27, max: 18.69% of total area) showed higher proteoglycan synthesis compared to GF/ GlcNÁHCl and GF, but again not statistically significant (p = 0.159 and 0.467, respectively). All groups with GF showed a synthesis of COL1 and COL2 (Fig. 6) . No synthesis of either collagen was observed in samples without GF and therefore the images were omitted. The total matrix production observed in SEM was similar between the GF and GF/GlcNÁHCl groups (Fig. 7) . Nevertheless, the highest biosynthesis was observed in the GF/GlcNAc group. The superficial porosity on top of the chitosan scaffold was completely closed by cells and matrix, while uncovered chitosan parts and pores can be seen in GF and GF/GlcNÁHCl, respectively.
Discussion
The supplementation of GlcNÁHCl in low and high doses has shown a deleterious effect on cell proliferation and proteoglycan synthesis. The nutritional imbalance created by GlcNÁHCl supplementation could promote suppression of the chondrogenic effect of GF through the inhibition of the TGF-br expression [33] , and inhibition of IRS-1 [37] and IGF [38] phosphorylation. To test this hypothesis, a group with TGF-b3 ? IGF-I, termed ''GF'', and GF/ GlcNÁHCl were compared in two experimental settings: 48 h monolayer culture and 30 days in 3D culture. The proliferation was inhibited by the addition of GlcNÁHCl to GF, as observed in DNA, resazurin redox, and lactate quantifications. Conversely, a proliferative effect was observed in the long time 3D culture. Interestingly, this higher cell concentration was not traduced in higher proteoglycan synthesis, since there was no difference between GF and GF/GlcNÁHCl. This result suggests that GlcNÁHClGlcNÁHCl was not used as a substrate for proteoglycan synthesis. The concentration of GlcN is very low in cartilage, and glucose is the main substrate for biosynthesis via HBP. Nevertheless, studies that have reported biosynthesis impairment with GlcNÁHCl supplementation have suggested that the glucose metabolism is modified. GlcN increases the post-translational inhibition of IRS-1 [46] and IGF-Ir [38] , which results in insulin resistance, decreased glucose uptake [39] , and downregulates the expression of GLUT types with higher affinity for glucose via depletion of the ATP and hexosamine pathways [43, 47, 48] . Furthermore, upon entering the cell, GlcN undergoes phosphorylation by glucokinase and competes with glucose for binding to glucokinase [42] , which inhibits the glucose metabolism. An even stronger proliferative effect was observed with GlcNAc supplementation. The addition of GlcNAc to GF did not inhibit the cell proliferation in the monolayer culture; however, it increased the cell metabolism compared to GF. In the long-term culture, the addition of GlcNAc greatly improved the cell proliferation and proteoglycan synthesis compared to GF/GlcNÁHCl and GF alone. These results suggest that GlcNÁHCl and GlcNAc have a differential metabolic effect, as shown in a previous study [43] . First, GlcNAc (1 and 5 mM) does not compete for GLUT, thus perming the normal glucose uptake [42, 43] . Second, GlcNAc does not interfere in glucose metabolism. GlcNAc undergoes phosphorylation by GlcNAc kinase and does not compete with glucose for glucokinase [49, 50] . Moreover, this product of GlcNAc phosphorylation (GlcNAc-6 phosphate) enters the hexosamine pathway more distally than GlcN-6 phosphate and does not possess any known negative allosteric effects toward glucokinase [49] . Beyond GlcNAc does not change the glucose metabolism, its supplementation might directly be used as a substrate for proteoglycan synthesis. Therefore, these findings may account, at least in part, for the different results between GlcNÁHCl and GlcNAc observed in the present study.
The natural cartilage matrix is mainly composed of COL2 with very small amounts or absence of COL1 [51] . The synthesis of COL2 is mediated by GF. The cells under the influence of GF, and GF supplemented with GlcNÁHCl or GlcNAc synthesized both COL1 and COL2. The presence of COL2 confirmed the maintenance of the chondrocytic phenotype and reinforced the non-inhibitory effect of GlcNÁHCl and GlcNAc on GF. However, the synthesis of COL1 indicated the existence of dedifferentiated cells.
The difference between GlcNÁHCl and GlcNAc on cell proliferation and matrix synthesis has been reported in previous monolayer and 3D culture studies. Whereas small concentrations of GlcNÁHCl (0.5 and 5 mM) inhibited cell proliferation [40, 52] and decreased lactate and glycosaminoglycan synthesis [40] [41] [42] , GlcNAc did not alter the proliferation [41, 52] and proteoglycan synthesis [12, 42, 52] . However, contradicting results with GlcNÁHCl supplementation were also recorded. An improvement of COL2 and proteoglycan synthesis was observed with a supplementation of 2 mM GlcNÁHCl [13] and might be related to the upregulation of the TGF-b expression [13, 18] . Conversely, the COL2 expression [41, 53] and synthesis [53] were not changed in other studies.
Due to the suppressive effect of GlcN when added to GF on cell proliferation in the monolayer culture compared to GlcNAc, the GlcN and GlcNAc were tested without growth factors in 3D culture. However, neither altered the cell proliferation compared to control. The low cell concentration resulted in non-significant synthesis of the matrix. Therefore, GlcN and GlcNAc have no effect when added without growth factors in a long-time culture.
In summary, GlcNÁHCl and GlcNAc without GF have no effect on cell proliferation and matrix synthesis. When added to GF, the inhibitory effect of GlcNÁHCl, observed in the monolayer short-term culture, was not observed in the 3D long-term culture. GlcNÁHCl improved cell proliferation but did not benefit proteoglycan synthesis. However, the addition of GlcNAc to GF resulted in higher cell proliferation and synthesis of proteoglycan compared to GF and GF ? GlcNÁHCl. The presence of collagen I and II was observed in all groups containing GF. Therefore, although GlcNÁHCl and GlcNAc do not inhibit the effect of GF, GlcNAc at the concentration used is a better option for the proliferation and synthesis of PG in cartilage engineering.
